Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

News archive

Adherence to metformin in people with type 2 diabetes mellitus: results from the first New Zealand-wide study

Tuesday, 19 November 2019 2:08pm

In a national study, researchers from the Pharmacoepidemiology Research Network at the University of Otago have found sub-optimal levels of adherence to metformin, the recommended first-line drug used to treat type 2 diabetes.

^ Top of Page

Prevention of acute coronary events: are people with chronic obstructive pulmonary disease missing out?

Friday, 15 November 2019 4:57pm

There appears to be a particular reluctance to prescribe beta-blocker drugs to people with chronic obstructive pulmonary disease (COPD) who develop acute coronary syndrome (heart attacks and unstable angina) according to University of Otago researchers from the Pharmacoepidemiology Research Network.

^ Top of Page

PhD candidate receives award

Tuesday, 11 June 2019 8:42am

For the second year in a row, Sarah Donald has received a prize in the Dunedin School of Medicine’s postgraduate poster competition.

^ Top of Page

First paper published from PhD research

Tuesday, 6 November 2018 3:52pm

PhD candidate Sarah Donald and her supervisory team have published the first paper from her PhD research.

^ Top of Page

No increased risk of lung infections among infants using popular anti-reflux medicines

Tuesday, 18 September 2018 10:16am

New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies.

^ Top of Page

PhD candidate receives award

Thursday, 31 May 2018 12:07pm

Sarah Donald has received a prize in the 2018 Dunedin School of Medicine postgraduate poster competition for a poster which outlines the process of generating a pregnancy cohort for medicine utilisation and safety studies in New Zealand.

^ Top of Page

Prescribing guidelines not always followed for patients on cholesterol-lowering drug

Friday, 4 May 2018 10:40am

New Zealand prescribers do not always follow guidelines when prescribing other medicines to patients taking simvastatin, according to University of Otago researchers from the Pharmacoepidemiology Research Network. 

^ Top of Page

Chronic lung disease treatment in New Zealand often not consistent with international guidelines

Tuesday, 19 December 2017 10:53am

University of Otago researchers have found that the treatment of chronic obstructive pulmonary disease (COPD) in New Zealand frequently does not conform to international guidelines.

^ Top of Page

No evidence higher doses of cholesterol-lowering drug increase risk of acute kidney damage

Monday, 31 July 2017 3:37pm

New Zealanders taking a higher dose of simvastatin, one of the cholesterol-lowering statin drugs used to prevent heart attacks and strokes, do not appear to have a higher risk of acute kidney damage than those taking a lower dose, according to University of Otago researchers from the Pharmacoepidemiology Research Network.

^ Top of Page

Researchers funded to investigate possible adverse effect of a common lung disease treatment

Thursday, 15 June 2017 9:23am

The University of Otago’s Dr Lianne Parkin and colleagues will receive a Health Research Council grant to investigate whether particular drugs used to treat a common lung disease put people at greater risk of heart attacks.

^ Top of Page

Off-label prescription of proton pump inhibitors to New Zealand infants is common

Thursday, 4 May 2017 12:09pm

Off-label use of proton pump inhibitors is common among New Zealand infants, according to new University of Otago research.

^ Top of Page

Otago researchers receive new joint pharmaceuticals research funding

Thursday, 2 March 2017 4:32pm

Researchers from University of Otago are among the first recipients of two new grants from PHARMAC and the Health Research Council of New Zealand (HRC).

^ Top of Page

Disparities in insulin pump use by New Zealanders with type 1 diabetes: Otago research

Friday, 23 September 2016 11:32am

There are significant demographic and regional disparities in the use of insulin pumps in New Zealand, according to new University of Otago research.